Cindy Bayley
Angel Investor
Cindy Bayley is a startup investor. Dr Bayley is an affiliate of ARCH who focuses on life-science businesses and is co-founder of several ARCH portfolio companies, including deCODE genetics, an Icelandic diagnostics company, Adolor, a pharmaceutical firm developing novel analgesics, and Elixir Pharmaceuticals, an anti-aging and metabolic disease company, and has been instrumental insourcing companies such as Alnylam Pharmaceuticals and Agios Pharmaceuticals. Early in her career, she was a field engineer with Schlumberger Offshore Services. Dr. Bayley holds a B.S. in Physics from the University of Rochester, and a Ph.D. in Virology and an M.B.A. from the University of Chicago.
Last updated:
For AI agents: llms.txt
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
How do I contact Cindy Bayley?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!